Product Category
Formulation
MEGESTROL ACETATE: 125 mg/mL Oral suspension
Delivery Method
Oral Suspension
Status
Prescription
ANDA #
203139
Approval Date
20140827
Therapeutic Equivalents
Manufacturers
References